Skip to content

Comparative study about the effectiveness and the safety of atorvastatin original drug and generic drug.

Comparative study about the effectiveness and the safety of atorvastatin original drug and generic drug. - Comparative study of the atorvastatin original drug and generic drug.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034049
Enrollment
68
Registered
2018-09-06
Start date
2015-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

The group first, it takes 12 weeks for an original drug once a day, morning, noon, evening or before sleeping, and then taking generic drug under the same condition for 12 weeks. The group first, it

Sponsors

Kanagawa Association of Medical and Dental Practitioners
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patient who agreed to participate in research by his / her own free will 2. Patients with primary prevention of dyslipidemia who have not taken statins for 3 months or more at the time of participation in the study 3. For diabetes patients, patients with HbA1c of less than 7.0% for at least 6 months prior to the start of study (for elderly people aged 75 and older, follow the "Glucose Control Target 2016 for Elderly Diabetes" target over 6 months Patient achieving)

Exclusion criteria

Exclusion criteria: 1. Patients with malignancy 2. Patients with malnutrition (serum albumin less than 3.5 g / dl) 3. Patients with thyroid disease 4. Patients taking fibrates

Design outcomes

Primary

MeasureTime frame
LDL-c

Countries

Japan

Contacts

Public ContactMika Okayama

Kanagawa Association of Medical and Dental Practitioners Department of Clinical Research

okayama_mika@doc-net.or.jp045-313-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026